China Steel Chemical Corporation (1723) Fair Value & Analysis
Basic Materials · TW · Market cap 20.2B TWD
Analysis
China Steel Chemical Corporation (1723) currently trades at 86.60 TWD, while our model-based Fair Value estimate is 34.42 TWD — implying the stock looks roughly 60.3% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
China Steel Chemical Corporation, together with its subsidiaries, engages in the production, processing, and sale of coal tar distillation, light oil, coke, and refined carbon material products in Taiwan, China, Australia, and internationally. The company offers coal chemicals, including coal and special tar pitches; creosote oils and refined tars; refined naphthalene mothball and chemical grades; benzene and toluene aromatics; and metallurgical cokes and dehydrated coke fines. It also provides carbon materials, such as anode-material precursors; anode materials for lithium-ion battery; activated carbon for EDLC; and fine carbon materials comprising green mesophase powder, carbonized mesophase powder, mesophase graphite powder, and advanced carbon materials. In addition, the company engages in the trading of related upstream and downstream products; production and sale of blast furnace slag powder and cement, gas-cooled blast furnace slag and converter, magnetic materials, specialty…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.